中國的眼科市場(2023年):2022年～2028年的各地區分析

本報告審視了中國眼科市場，分析了需求量和收入，並預測了未來五年的表現。競爭對手佔有率按產品類別進行分析，對 32 個競爭對手進行了簡介、其產品、戰略市場地位、背景和前景。

樣品view

目錄

• 人口統計，中國經濟，包含中國的醫療基礎設施的分析中國家概要
• 疾病盛行率資料
• 眼科醫生，外科醫生，驗光師，醫院，診療所
• 手術治療
• 手術器具和技術的使用情形
• 眼科醫藥品治療方法
• 市場實際成果的5年預測
• 處理中國眼科產品的企業清單
• 競爭企業32公司的簡介

What's New

The new "2023 China Ophthalmic Market Report" features updated market forecasts through 2028 now in Chinese yuan, expanded analysis of regulations, and more detail on five-year plan goals. The report now covers more Chinese companies, including more competitor profiles, in addition to providing more analysis of ophthalmic product candidates at Chinese pharmaceutical companies and a refreshed listing of companies with ophthalmic products in China.

SAMPLE VIEW

The "2023 China Ophthalmic Market Report" covers all aspects of China's ophthalmic market, providing a comprehensive overview of the Chinese population and economic conditions, discussing key strategic issues, studying disease prevalence, and analyzing surgical and therapeutic approaches, including both commercialized and pipeline products. The report analyzes unit demand and revenue, and forecasts future performance over the next five years. Competitor share is analyzed by product category and 32 competitors are profiled, with discussion of their products, strategic market position, background, and outlook.

The report offers an in-depth examination of the ophthalmic market in China, discussing important trends and key factors for future success. The report looks at the market's evolution and forecasts growth over the next five years for 10 submarkets: cataract, refractive, cornea, glaucoma, retina, dry eye, diagnostic equipment, multi-specialty lasers, surgical instruments, and single-use surgical devices.

The following information is also included:

• Overview of China, including an analysis of population demographics, the Chinese economy, and China's health care infrastructure.

• Disease prevalence data.

• Ophthalmologists, surgeons, optometrists, hospitals, and clinics.

• Surgical treatments.

• Surgical instrument and technology usage.

• Ophthalmic pharmaceutical treatment regimens.

• Five-year forecasts for market performance.

• List of companies with ophthalmic products in China.

• 32 competitor profiles.

Author Profile:

Peter Downs

Peter Downs has more than 30 years of experience as a business and medical journalist and investigative reporter. He has written for a variety of medical industry publications, including the Medical Business Journal, CBS HealthWatch, and Oncology News International.

Prior to joining Market Scope in 2015 and turning his attention to ophthalmology, Peter analyzed markets for organ and tissue transplantation. Since joining Market Scope, he has traveled to several markets outside the US, including China, Europe, and India, to study ophthalmology at the local level.

In addition to his research and writing efforts on the ophthalmic market, he is also a contributor to Ophthalmic Market Perspectives, the firm's monthly industry newsletter.